Detalles de la búsqueda
1.
Stepwise prolongation of overall survival from first to third generation EGFR-TKIs for EGFR mutation-positive non-small-cell lung cancer: the Tokushukai REAl-world Data project (TREAD 01).
Jpn J Clin Oncol
; 54(3): 319-328, 2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37997468
2.
The efficacy of amrubicin on central nervous system metastases originating from small-cell lung cancer: a case series of eight patients.
Invest New Drugs
; 33(3): 755-60, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25846908
3.
A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib.
Jpn J Clin Oncol
; 44(9): 868-71, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25028698
4.
Comparison of chemotherapeutic efficacy between LCNEC diagnosed using large specimens and possible LCNEC diagnosed using small biopsy specimens.
Int J Clin Oncol
; 19(1): 63-7, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23250620
5.
[Evaluation of recurrence rates on change in hormone receptor and human epidermal growth factor receptor 2 status after neo-adjuvant chemotherapy in breast cancer patients].
Gan To Kagaku Ryoho
; 41(3): 313-6, 2014 Mar.
Artículo
en Japonés
| MEDLINE | ID: mdl-24743275
6.
Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1.
Cancer Chemother Pharmacol
; 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38584202
7.
Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma.
JTO Clin Res Rep
; 5(1): 100613, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38229769
8.
Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 10(3): 315-324, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38127362
9.
A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary site.
Invest New Drugs
; 31(6): 1568-72, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23975509
10.
A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer.
Invest New Drugs
; 31(3): 599-604, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22623066
11.
The role of ßIII-tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapy.
Int J Clin Oncol
; 18(3): 371-9, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22358390
12.
Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kinases, in Japanese patients with advanced solid tumors.
Invest New Drugs
; 30(6): 2352-63, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22249430
13.
HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non-Small Cell Lung Cancer.
Clin Cancer Res
; 28(2): 390-403, 2022 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34921025
14.
The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLC.
JTO Clin Res Rep
; 3(8): 100373, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35941997
15.
Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: a pooled analysis of published reports.
Cancer Sci
; 102(5): 1032-7, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21272159
16.
Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors.
Clin Cancer Res
; 15(11): 3872-80, 2009 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19470738
17.
Phase I clinical and pharmacokinetic study of RAD001 (everolimus) administered daily to Japanese patients with advanced solid tumors.
Jpn J Clin Oncol
; 40(1): 17-23, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19783551
18.
N-telopeptide of type I collagen is useful for monitoring therapeutic response in non-small cell lung cancer patients with bone metastases.
Int J Clin Oncol
; 15(5): 484-8, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20556457
19.
Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancer.
Int J Clin Oncol
; 15(2): 161-5, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20198400
20.
[Evaluation of chemotherapy, especially combined therapy with Carboplatin Plus Etoposide(CE), in patients aged > or =80 years old with extensive-disease small-cell lung cancer].
Gan To Kagaku Ryoho
; 37(6): 1041-4, 2010 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-20567104